Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?

To: Lyn Benson who wrote (295)	3/28/2000 10:15:00 AM
From: tom r. phillips	Read Replies (1) \| Respond to of 668

Lyn -- the status of OP-1 approval process is up in the air, with no announced time of FDA advisory panel review. the balance of opinion that i've seen is that there may not be significant movement before late this year. approval in Australia and Europe may be sooner. in the near term, CBMI stock price, IMHO, will be under the sway of the biotech sector in general, with influence also by the approach of the pending merger of CBMI with Ontogeny and Reprogenesis in June. i suggest sifting through the yahoo message board -- there's some gold among the garbage. Tom